Chilco River Holdings, Inc. (CRVH) Engages Solutions Group Accounting to Accelerate Financial Transparency, Compliance, and Uplisting InitiativesCompany lays foundation for growth and expansion in 2026December 12, 2025 11:17 AM EST | Source: Chilco River Holdings, Inc.Los Angeles, California--(Newsfile Corp. - December 12, 2025) - Chilco River Holdings, Inc. (OTCID: CRVH) ("Chilco River"), a dynamic beverage company focused on strategic growth in the alcohol sector including luxury tequila, pr ...

Vancouver, British Columbia--(Newsfile Corp. - December 12, 2025) - Magma Silver Corp. (TSXV: MGMA) (OTCQB: MAGMF) (FSE: BC21) (WKN: A411DV) (the "Company" or "Magma") announced that its board of directors has approved the grant of a total of 50,000 incentive stock options (the "Stock Options") to certain of its directors, officers, consultants, and employees pursuant to the Company's Stock Option Plan. Such Stock Options are exercisable into Common Shares at an exercise price of $0.27 per share for a peri ...

Core Points - Mr. Michael Higginson will not stand for election as a Director at the Annual General and Special Meeting on December 16, 2025 [1] - The Board recognizes three Director positions are available, with only three candidates standing for election, and recommends shareholders vote in favor of David Potter [2] - As a result of Mr. Higginson's decision, Resolution 2(c) will be withdrawn from the meeting agenda, but he will continue to serve as Company Secretary and Chief Corporate Officer [3] Company Information - The announcement was authorized for release by the Board of Besra Gold Inc [4]

Toronto, Ontario--(Newsfile Corp. - December 12, 2025) - Excellon Resources Inc. (TSXV: EXN) (OTC Pink: EXNRF) (FSE: E4X2) ("Excellon" or the "Company") announces that, pursuant to its Share Incentive Plan, it has granted an aggregate of 4,600,000 stock options to directors and officers of the Company. The options are exercisable at $0.38 per share for a period of three years and will vest one-quarter immediately and one-quarter on each of the dates that are 6, 12 and 18 months from the date of grant.About ...

Vancouver, British Columbia--(Newsfile Corp. - December 12, 2025) - SureNano Science Ltd. (CSE: SURE) (OTCQB: SURNF) (the "Company" or "SureNano") announces that it has granted 1,500,000 stock options to various directors, officers, and Consultants of the Company. The options will vest immediately and may be exercised at an exercise price of CAD $0.18 per common share, for a period of 5 years from the date of issuance or earlier in accordance with the Company's incentive stock option plan.Following the gra ...

Vancouver, British Columbia--(Newsfile Corp. - December 12, 2025) - Hertz Energy Inc. (CSE: HZ) (OTCQB: HZLIF) (FSE: A340) ("Hertz" or the "Company") is pleased to announce a non-brokered private placement for gross proceeds of up to $440,000 (the "Private Placement").The Private Placement will consist of up to 4,400,000 units of the Company (the "Units") at a price of $0.10 per Unit gross proceeds of up to $440,000 (the "Offering"). Each Unit will consist of one (1) common share in the capital of the Comp ...

Core Insights - OneMeta Inc. is set to release its 2026 Shareholder Update Video on December 18, 2025, which will outline the company's strategic momentum and priorities for the upcoming year [1][2] - The update will emphasize OneMeta's progress in 2025 and its execution plan for scalable growth in real-time multilingual understanding [3][4] Company Overview - OneMeta specializes in AI-driven multilingual communication technologies, offering solutions such as instant speech-to-speech translation, transcription, and live captioning across over 150 languages [5] - The company's mission is to enhance global communication, making it fast, seamless, secure, and universally accessible [5] Strategic Focus - The 2026 strategy will focus on responsible innovation, disciplined growth, and operational readiness, with advancements in the VerbumSuite platform aimed at improving speed, accuracy, and enterprise integration [8] - OneMeta aims to expand in key verticals where multilingual communication is increasingly essential [8]

Zhibao Technology Inc. Launches Zhibao Yingshi - A Joint Venture to Accelerate Development of Medical Insurance ProductsDecember 12, 2025 9:00 AM EST | Source: Zhibao Technology Inc.Shanghai, China--(Newsfile Corp. - December 12, 2025) - Zhibao Technology Inc. (NASDAQ: ZBAO) ("Zhibao," "we," or the "Company"), a leading and high growth InsurTech company primarily engaging in providing digital insurance brokerage services through its operating entities in China, today announced the commencement ...

Core Viewpoint - MoonLake Immunotherapeutics is facing a securities fraud class action lawsuit due to alleged misrepresentations regarding its clinical data and the efficacy of its investigational drug sonelokimab [1][3][4]. Group 1: Lawsuit Details - A lawsuit has been filed against MoonLake and certain senior executives for potential violations of federal securities laws, specifically under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 [1][3]. - Investors have until December 15, 2025, to request to be appointed to lead the case, which is pending in the U.S. District Court for the Southern District of New York [3]. Group 2: Company Background - MoonLake is a clinical-stage biotechnology company focused on developing therapies for inflammatory diseases, particularly through its investigational drug sonelokimab [4]. - The company claimed that its "strong clinical data" from the Phase 2 MIRA trial indicated a higher clinical response for patients, suggesting a competitive advantage over traditional monoclonal antibody treatments [5]. Group 3: Allegations and Impact - The lawsuit alleges that the clinical data and Nanobody structure of sonelokimab did not provide a superior clinical benefit compared to competitors, raising doubts about the drug's regulatory approval and commercial viability [6]. - Following the announcement of disappointing results from the Phase 3 VELA trials, MoonLake's stock price plummeted nearly 90%, from $61.99 per share to $6.24 per share within a few days [7].

Core Viewpoint - Stride, Inc. is facing a class action lawsuit for securities fraud, which has led to significant stock price drops due to alleged violations of federal securities laws [1][3]. Group 1: Lawsuit Details - A class action lawsuit has been filed against Stride, Inc. and certain senior executives for securities fraud, with investors encouraged to contact BFA Law by January 12, 2026 [1][3]. - The lawsuit claims violations under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934, and is pending in the U.S. District Court for the Eastern District of Virginia [3]. Group 2: Allegations Against Stride - Stride is accused of inflating enrollment numbers by retaining "ghost students" to secure state funding, ignoring compliance requirements, and providing a poor customer experience that led to higher withdrawal rates and lower conversion rates [4][5]. - The company had previously claimed to be experiencing growth and strong demand for its products, which is now being challenged by the allegations [4]. Group 3: Stock Price Impact - Following the fraud allegations reported on September 14, 2025, Stride's stock dropped by $18.60 per share, or over 11%, from $158.36 to $139.76 [5]. - On October 28, 2025, Stride admitted to issues with customer experience, leading to an estimated 10,000-15,000 fewer enrollments, which caused the stock to plummet by $83.48 per share, or more than 54%, from $153.53 to $70.05 [6].